文献速递主动脉疾病

15年单中心队列中先天性 vs 退行性主动脉病行孤立性胸主动脉置换的中期结局

Midterm outcomes of isolated thoracic aortic replacement in congenital versus degenerative aortopathy in a 15-year institutional cohort.
PubMed 文献 · J Vasc Surg · 2022-08-30

该单中心回顾性队列纳入2005至2020年接受孤立性开放胸主动脉置换的62例患者,比较结缔组织病(CTD)与退行性病变的中期结局。CTD组更年轻、吸烟和高血压比例更低、夹层成分更多、修复时主动脉直径更小。两组住院死亡率和截瘫率无差异,5年CTD组远端动脉瘤样改变和主动脉外动脉瘤更多,但再干预率无差异。

要点

  • CTD组18例(29%),其中16例为马方综合征(77.8%)。
  • CTD组修复时100%有夹层成分 vs 非CTD组59.1%,修复直径5.9 cm vs 6.6 cm。
  • 5年CTD组远端动脉瘤样改变88.9% vs 47.7%,主动脉外动脉瘤41.2% vs 2.3%。

核心结论

  • 开放胸主动脉置换对先天性胸主动脉疾病患者是耐受良好且持久的治疗选择,但携带显著手术风险和潜在并发症。
  • 两组再干预率相当,提示CTD主动脉修复后重塑几乎普遍以初始扩张为特征,但多数变化成功稳定且未进展为更高再干预率。
  • 需要胸主动脉置换的CTD和非CTD患者常需未来主动脉干预,因此 vigilant surveillance is warranted。

研究设计与样本

  • 单中心学术中心2005至2020年所有接受孤立性开放胸主动脉置换的患者被纳入。
  • 根据与先天性主动脉病相关的记录基因突变将患者分类为CTD或非CTD。
  • 共纳入62例患者,中位随访58个月(范围19-81个月),CTD组59个月 vs 非CTD组51.5个月。
  • 使用描述性统计和Kaplan-Meier生存分析比较两组住院和中期结局。

主要发现

  • CTD组18例(29%),其中16例为马方综合征(77.8%)。
  • CTD组较非CTD组更年轻(45.8岁 vs 60.9岁),吸烟率更低(5.6% vs 56.8%),高血压率更低(97.7% vs 72.2%;均P < .01)。
  • CTD组修复时夹层成分比例更高(100% vs 59.1%),修复时主动脉直径更小(5.9 cm vs 6.6 cm;均P < .05)。
  • 住院结局无差异:死亡率4.5% vs 5.6%,截瘫率2.3% vs 0%(均P > .05)。
  • 5年时CTD组远端动脉瘤样改变更多(88.9% vs 47.7%),主动脉外动脉瘤更多(41.2% vs 2.3%;均P < .05)。

临床怎么用

  • 作者认为开放胸主动脉置换是先天性胸主动脉疾病患者耐受良好且持久的治疗选择。
  • 作者认为需要胸主动脉置换的CTD和非CTD患者常需未来主动脉干预,vigilant surveillance is warranted。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Open aortic replacement represents the only approved option to address thoracic aortopathy among patients with connective tissue disorders (CTD). The aim of our study was to investigate contemporary midterm outcomes of isolated thoracic aortic replacement in patients with CTD versus degenerative pathology in a large institutional cohort. METHODS: All patients undergoing isolated open thoracic aortic replacement at a single academic center from 2005 to 2020 were included. Patients were classified as having CTD or not having CTD based on documented genetic mutations associated with congenital aortopathy. In-hospital and midterm outcomes, including mortality, paraplegia, development of new arterial pathology on surveillance imaging, and the need for future operations, were compared between groups using descriptive statistics and Kaplan-Meier survival analysis. RESULTS: Overall, 62 patients were included with a median follow-up of 58 months (range, 19-81 months) (59 months for those with CTD vs 51.5 months for those without CTD). CTD was present in 18 patients (29%), with 16 having Marfan syndrome (77.8%). Patients with CTD were younger than patients without CTD (45.8 years vs 60.9 years) and had lower rates of smoking (5.6% vs 56.8%) and hypertension (97.7% vs 72.2%; all P < .01). Patients with CTD were more likely to have a dissection component at the time of repair compared with patients without CTD (100% vs 59.1%) and underwent repair at smaller aortic diameters (5.9 cm vs 6.6 cm; both P < .05). There were no differences in in-hospital outcomes between the two groups, including mortality (4.5% vs 5.6%) and paraplegia (2.3% vs 0%; both P > .05). At 5 years, patients with CTD were more likely to have developed aneurysmal changes distal to their thoracic repair (88.9% vs 47.7%) and extra-aortic arterial aneurysms (41.2% vs 2.3%; both P < .05). However, on survival analysis, there were no differences in freedom from additional vascular procedures (hazard ratio,1.76; P = .333) or, specifically, additional aortic procedures (hazard ratio, 1.81; P = .380) between the two groups. There was only one anastomotic complication identified on longitudinal follow-up, which occurred in a patient without CTD 8 years after the index operation. CONCLUSIONS: Although carrying significant operative risks and the potential for morbidity, open thoracic aortic replacement represents a well-tolerated, durable treatment option for patients with congenitally mediated thoracic aortic disease. Because both patients with and without CTD who required thoracic aortic replacement often need future aortic intervention, vigilant surveillance is warranted. Equivalent intervention rates between the two groups suggest remodeling of the CTD aorta is almost universally characterized by initial postrepair dilation, but the majority of these changes successfully stabilize and do not progress to higher rates of intervention.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Sorber R, Tsai LL, Hicks CW, et al. Midterm outcomes of isolated thoracic aortic replacement in congenital versus degenerative aortopathy in a 15-year institutional cohort. J Vasc Surg. 2022. PMID: 36055553. doi:10.1016/j.jvs.2022.05.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。